By PPN News Staff
The FDA approved meropenem-vaborbactam (Vabomere, Rempex Pharmaceuticals) for adults with complicated urinary tract infections (cUTI), including pyelonephritis, a type of kidney infection, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial agent, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.
The safety and efficacy of meropenem-vaborbactam were evaluated in a clinical trial involving 545 adults with